# OnCo record arvinas (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/arvinas/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "arvinas" ;
  schema:name "Arvinas"@en ;
  schema:description "PROTAC pioneer whose vepdegestrant (Veppanu) became the first approved targeted protein degrader in May 2026; Rigel Pharmaceuticals now sells it under licence."@en ;
  schema:url <https://onco.cc/companies/arvinas/>, <https://www.arvinas.com> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.arvinas.com>, <https://www.sec.gov/Archives/edgar/data/1655759/000162828026029210/arvn-20260501.htm>, <https://www.sec.gov/Archives/edgar/data/1655759/000162828026033874/arvn-20260511.htm>, <https://www.sec.gov/Archives/edgar/data/1655759/000162828026043559/arvn-20260611.htm> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:drugs <https://onco.cc/drugs/vepdegestrant/> ;
  onco:companies <https://onco.cc/companies/rigel-pharmaceuticals/>, <https://onco.cc/companies/pfizer/> ;
  onco:trials <https://onco.cc/trials/nct07023731/>, <https://onco.cc/trials/nct07749586/> .